Go back to the main page.
Transforming Today's Science Into Tomorrow's Cures
Samaritan's collaborative researchers have made important patented discoveries in the fields of, central nervous system diseases, such as, Alzheimer's disease; cancer; cardiovascular disease; and infectious diseases, such as, AIDS, and Hepatitis C. These discoveries have positioned us with a rich pipeline of new drugs with novel mechanisms of actions to develop.
Samaritan Pharmaceuticals, Inc. is an entrepreneurial biopharmaceutical company focused on the development and marketing of innovative therapeutics. At Samaritan Pharmaceuticals our mission has been to create life-saving drugs for people suffering from AIDS, Alzheimer’s, heart disease and cancer. View all the latest press releases and news articles focused on Samaritan Pharmaceuticals, Inc. These publications, called peer-reviewed journals, are scholarly periodicals requiring each article submitted be judged by an independent panel of experts (scientific peers) to authenticate the accuracy of the material. The number of articles printed and the variety of publications accepting the article serve to underscore the legitimacy of information. Samaritan has collaborative relationships with other pharmaceutical companies to commercialize branded approved prescription products in selected niche territories, such as, in Greece, Albania, Bosnia, Bulgaria, Croatia, Cyprus, Czech Republic, Egypt, FYROM, Hungary, Montenegro, Poland, Romania, Serbia, Slovakia, Slovania, Syria and Turkey. Before a drug can be offered to the public it must go through several phases of rigorous testing to make sure it is safe, efficient and does what it says it can do. The testing is mandated and overseen by the U.S. Food and Drug Administration (FDA) which is part of the U.S. Department of Health and Human Services. SAMARITAN PIPELINE - (MECHANISM OF ACTION VIDEOS)
Go back to the main page. Contact Samaritan Pharmaceuticals, Inc. Find what you are looking for in our website.
EXECUTIVE BIOGRAPHIES

Erasto R. C. Saldi, M.D.
Chairman, Science and Technology Advisory Committee

Dr. Erasto Saldi is a goal oriented, entrepreneurial physician with expertise in electronic medical software; with a forte in hospital inpatient care and proficiency in contract formulations in all models of hospitalists environments.

Dr. Saldi has extensive experience as an Internist, Principal Investigator, Manager of clinical research trials, as well as with the writing of protocols. Dr. Saldi's scientific and clinical research management, with drugs such as Clonidine in the Philippines, brings a unique perspective in areas that are of considerable importance to Samaritan right now.

1999 - present FMC - Fremont Inpatient Team, Las Vegas, NV
Medical Director
-Increased inpatient revenue from $450,000 to $3.2 million a year in two years.
-Managed and supervised a team of 15 hospitalists.
-Obtained and negotiated contracts for the group resulting in increased revenue by 200%.
Established a network of specialty physicians which enhanced delivery of care to plan members.

2001- present Nevada Care, Inc. Las Vegas, NV
Co-chairman, Physicians Advisory Committee
-Formulated credentialing guidelines for plan providers.
-Evaluated credentials of applicant plan providers.
Formulated and implemented guidelines for improvement in quality of care.

1999- present Desert Lane Care Center Las Vegas, NV
Medical Director
-Improved physician compliance with medical record keeping.
-Formulated patient care protocols resulting in improvement of patient care.
Formulated and implemented guidelines for improvement in quality of care.

1999- present Cheyenne Care Center Las Vegas, NV
Medical Director
-Improved physician compliance with medical record keeping.
-Formulated patient care protocols resulting in improvement of patient care.
Formulated and implemented guidelines for improvement in quality of care.

2000 – Present MediPacks, Inc. Las Vegas, NV
Chief Medical Officer and Chairman of the Board
-Founder and Majority shareholder of company
-Co-developer and co-designer of MediPacks General Medicine Module, a charge and data capture, EMR software for general practitioners

1997 - 1999 MediPacks, Inc. Las Vegas, NV
Chief Medical Officer and Chairman of the Board
-Founder and Majority shareholder of company
-Co-developer and co-designer of MediPacks General Medicine Module, a charge and data capture, EMR soft ware for general practitioners

1997 – 2000 Prime Medical Associates Las Vegas, NV
President and CEO
-Founder and Majority shareholder of company.
-Responsible for practice growth by 300% in first two years.
-Increased revenue by 200% year to year from zero patient base to $3.8 M after two years.
-Expansion from one clinic to four clinics in two years

1997 – 1998 University of Nevada School of Medicine Las Vegas, NV
Assistant Clinical Professor, Internal Medicine
-Trained residents in hospital program.
-Delivered lectures as assigned.

1996 – 1997 University of Nevada School of Medicine Las Vegas, NV
Chief Resident, Internal Medicine
-Improved morale and accomplished fair assignment of physician residents work load and calls.
-Co- developed and Co- established with the hospital pharmacy a standard evidence based heparin protocol for the whole hospital.
-Supervised and trained medical students and residents in clinical practice, hospital settings and clinical research.

Back to Board of Directors

Back to Science and Technology Advisory Committee

Partnering
Opportunities